Table 4.
Ligands | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
RbcL | 3PGK | GAPN | SPS II | Fba | Sbe I | WAXY | PRK | ATP A | ||
Receptor | RbcL | — | −709.8 | 0.00 | −661.01 | 0.00 | −554.51 | 0.00 | 0.00 | −647.4 |
3PGK | −731.7 | — | −653.19 | −560.03 | −664.83 | −546.61 | −629.23 | −601.07 | −638.00 | |
GAPN | 0.00 | −697.78 | — | −621.78 | 0.00 | −442.61 | 0.00 | 0.00 | 0.00 | |
SPS II | −668.63 | −563.23 | −564.06 | — | −549.66 | −389.00 | −497.30 | −604.34 | −530.92 | |
Fba | 0.00 | −646.49 | 0.00 | −564.97 | — | −654.16 | 0.00 | 0.00 | 0.00 | |
Sbe1 | −540.88 | 445.36 | −460.27 | −387.54 | −670.23 | — | −489.67 | −600.58 | −412.56 | |
WAXY | 0.00 | −684.00 | 0.00 | −509.77 | 0.00 | −470.18 | — | 0.00 | −422.82 | |
PRK | 0.00 | −614.7 | 0.00 | −537.44 | 0.00 | −528.05 | 0.00 | — | 0.00 | |
ATP A | −550.1 | −621.99 | 0.00 | −675.29 | 0.00 | −483.83 | −308.53 | 0.00 | — |